Multiple strategies for specific therapies are presently attempted in multiple sclerosis, in which an autoimmune reaction leads to demyelinisation within the central nervous system. Similar approaches are generally used in other potential autoimmune diseases. They try to interfere with the presentation and recognition of putative autoantigens by the immune system and also with the inflammatory process that gives rise to the demyelinating lesion. The authors review extensively these various prospects and their immediate implications for multiple sclerosis patients
Multiple Sclerosis is a chronic immune-mediated inflammatory disease of the Central nervous system, ...
International audienceMultiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of...
• Multiple sclerosis (MS) is an autoimmune disease of the central nervous system with a multifactori...
Multiple sclerosis (MS) afflicts about 2.5 million people globally and poses a major personal and so...
Multiple sclerosis is the most common inflammatory, chronic and degenerative condition of the centra...
Multiple sclerosis (MS) is a life-long, potentially debilitating disease of the central nervous syst...
The term neuroimmunology was first coined to refer to a generic involvement of the immune system in ...
Immunomodulatory/suppressive treatments are frequently used in neurological disorders affecting the ...
Multiple sclerosis is an autoimmune disease that demyelinates the nerves, the damage to the nerves i...
Immunomodulatory/suppressive treatments are frequently used in neurological disorders affecting the ...
BACKGROUND: The treatment of autoimmune disorders of the nervous system is based on interventions fo...
Multiple sclerosis (MS) is one of the most frequent neuroimmunological disorders of the central nerv...
Multiple sclerosis (MS) is a life-long, potentially debilitating disease of the central nervous syst...
Multiple sclerosis (MS) is a life-long, potentially debilitating disease of the central nervous syst...
Multiple sclerosis (MS) is the most common inflammatory demyelinating disorder of the central nervou...
Multiple Sclerosis is a chronic immune-mediated inflammatory disease of the Central nervous system, ...
International audienceMultiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of...
• Multiple sclerosis (MS) is an autoimmune disease of the central nervous system with a multifactori...
Multiple sclerosis (MS) afflicts about 2.5 million people globally and poses a major personal and so...
Multiple sclerosis is the most common inflammatory, chronic and degenerative condition of the centra...
Multiple sclerosis (MS) is a life-long, potentially debilitating disease of the central nervous syst...
The term neuroimmunology was first coined to refer to a generic involvement of the immune system in ...
Immunomodulatory/suppressive treatments are frequently used in neurological disorders affecting the ...
Multiple sclerosis is an autoimmune disease that demyelinates the nerves, the damage to the nerves i...
Immunomodulatory/suppressive treatments are frequently used in neurological disorders affecting the ...
BACKGROUND: The treatment of autoimmune disorders of the nervous system is based on interventions fo...
Multiple sclerosis (MS) is one of the most frequent neuroimmunological disorders of the central nerv...
Multiple sclerosis (MS) is a life-long, potentially debilitating disease of the central nervous syst...
Multiple sclerosis (MS) is a life-long, potentially debilitating disease of the central nervous syst...
Multiple sclerosis (MS) is the most common inflammatory demyelinating disorder of the central nervou...
Multiple Sclerosis is a chronic immune-mediated inflammatory disease of the Central nervous system, ...
International audienceMultiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of...
• Multiple sclerosis (MS) is an autoimmune disease of the central nervous system with a multifactori...